Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

3.1K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.1K
Spare Receptors01:30

Spare Receptors

4.8K
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
4.8K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

630
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
630
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

5.4K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.4K
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

112.6K
Overview
112.6K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

4.2K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Three-Dimensional Architectures for Silicon Wafer-Based Integrated Microenergy Storage Systems.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

Bright nanoparticle-labeled lateral flow immunoassay for rapid quantitative detection of tacrolimus in human plasma.

Mikrochimica acta·2025
Same author

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model.

Journal of visualized experiments : JoVE·2025
Same author

An interpretable machine learning model based on optimal feature selection for identifying CT abnormalities in patients with mild traumatic brain injury.

EClinicalMedicine·2025
Same author

Metabolomic machine learning-based model predicts efficacy of chemoimmunotherapy for advanced lung squamous cell carcinoma.

Frontiers in immunology·2025
Same author

Serum Albumin Levels and Length of Stay in Premature Infants.

Indian journal of pediatrics·2025

Related Experiment Video

Updated: Mar 8, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

3.9K

APPLs: More than just adiponectin receptor binding proteins.

Zhuoying Liu1, Ting Xiao1, Xiaoyu Peng1

  • 1Department of Metabolism and Endocrinology, Metabolic Syndrome Research Center of Central South University, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.

Cellular Signalling
|January 22, 2017
PubMed
Summary

APPL proteins are important signaling adaptors that help regulate metabolism. They interact with receptors for hormones like adiponectin and insulin. These interactions influence processes like lipid oxidation and glucose uptake. APPL1 and APPL2 are two major forms of these proteins. They differ in where they are found and how they function. APPL1 helps with adiponectin and insulin signaling. APPL2 plays a key role in endosomal trafficking. Understanding how APPLs work could lead to new treatments for metabolic and neurodegenerative diseases. This review highlights the growing evidence for their roles in cell signaling and metabolism.

Keywords:
APPL1APPL2AdiponectinEndosomeInsulinmetabolic signaling pathwaysinsulin receptor functionadiponectin receptor interactionendosomal trafficking mechanisms

Frequently Asked Questions

More Related Videos

Adipocyte-Specific ATAC-Seq with Adipose Tissues Using Fluorescence-Activated Nucleus Sorting
11:11

Adipocyte-Specific ATAC-Seq with Adipose Tissues Using Fluorescence-Activated Nucleus Sorting

Published on: March 17, 2023

2.8K
Isolation of Labile Multi-protein Complexes by in vivo Controlled Cellular Cross-Linking and Immuno-magnetic Affinity Chromatography
10:50

Isolation of Labile Multi-protein Complexes by in vivo Controlled Cellular Cross-Linking and Immuno-magnetic Affinity Chromatography

Published on: March 9, 2010

18.0K

Related Experiment Videos

Last Updated: Mar 8, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

3.9K
Adipocyte-Specific ATAC-Seq with Adipose Tissues Using Fluorescence-Activated Nucleus Sorting
11:11

Adipocyte-Specific ATAC-Seq with Adipose Tissues Using Fluorescence-Activated Nucleus Sorting

Published on: March 17, 2023

2.8K
Isolation of Labile Multi-protein Complexes by in vivo Controlled Cellular Cross-Linking and Immuno-magnetic Affinity Chromatography
10:50

Isolation of Labile Multi-protein Complexes by in vivo Controlled Cellular Cross-Linking and Immuno-magnetic Affinity Chromatography

Published on: March 9, 2010

18.0K

Area of Science:

  • Cell signaling pathways in metabolic medicine
  • Molecular mechanisms of insulin and adiponectin signaling

Background:

Obesity and diabetes remain widespread health challenges. Scientists have explored how cells regulate metabolism and energy balance. Adiponectin and insulin are key hormones involved in these processes. They act through receptors and signaling proteins in the cell. However, the exact mechanisms by which these signals are transmitted remain unclear. APPL proteins have emerged as potential players in this signaling network. Prior research has shown their involvement in lipid and glucose metabolism. But the full extent of their roles is still being uncovered. This gap motivated researchers to examine APPLs in more detail.

Purpose Of The Study:

This review aims to clarify the roles of APPL proteins in cellular signaling. The focus is on APPL1 and APPL2, two major isoforms. The study explores how these proteins interact with adiponectin and insulin receptors. The goal is to understand how APPLs influence metabolic processes. Researchers also investigate their impact on endosomal trafficking and other pathways. This work builds on existing knowledge of APPLs as signaling adaptors. The motivation is to identify potential therapeutic applications. Understanding these mechanisms may aid in treating metabolic and neurodegenerative disorders.

Main Methods:

The researchers conducted a comprehensive literature review. They analyzed published studies on APPL proteins and their interactions. Data were collected on APPL1 and APPL2 functions in signaling pathways. The review approach included examining studies on adiponectin and insulin signaling. Researchers also looked at how APPLs affect endosomal trafficking. They synthesized findings from multiple experimental models. The study compared results from in vitro and in vivo experiments. The synthesis focused on how APPLs contribute to metabolic regulation.

Main Results:

APPL1 was found to interact with adiponectin receptors. This interaction enhances lipid oxidation and glucose uptake. APPLs also play a role in insulin signaling pathways. They help mediate insulin's effects on cell metabolism. APPL1 and APPL2 differ in their tissue distribution and functions. APPL2 appears to regulate endosomal trafficking more prominently. The review highlights their roles in chromatin remodeling and apoptosis. These findings suggest APPLs are key regulators of metabolic homeostasis.

Conclusions:

The authors propose that APPLs are more than just receptor-binding proteins. They suggest these proteins have broader roles in cell signaling. APPL1 and APPL2 appear to influence multiple pathways. The review supports the idea that APPLs contribute to metabolic regulation. The findings may lead to new therapeutic strategies. The authors note the need for further research on APPL isoforms. They suggest that targeting APPLs could help treat metabolic diseases. The synthesis emphasizes the importance of understanding APPL signaling in health and disease.

APPL1 interacts with adiponectin receptors to enhance lipid oxidation and glucose uptake.

APPL1 and APPL2 both mediate insulin signaling but have distinct tissue distributions and functions.

APPL2 appears to play a significant role in regulating endosomal trafficking, which affects signaling efficiency.

APPLs contribute to chromatin remodeling, which influences gene expression and cell function.

APPL1 enhances glucose uptake by mediating adiponectin and insulin signaling pathways.

The authors suggest APPLs may lead to treatments for obesity, diabetes, and neurodegenerative diseases.